| Article Access Statistics|
| Viewed||860 |
| Printed||54 |
| Emailed||0 |
| PDF Downloaded||136 |
| Comments ||[Add] |
Click on image for details.
|Year : 2022
: 25 | Issue : 3 | Page
|Inadequate response to adenosine infusion during cardiac stress magnetic resonance imaging
Slomi Gupta1, Parimala Prasanna Simha1, Naveen G Singh1, PS Nagaraja1, Ashita Barthur2, Kartik Ganga2, V Prabhakar1
1 Department of Cardiac Anaesthesiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bannerghatta Road, 9th Block Jayanagar, Bangalore, Karnataka, India
2 Department of Radiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bannerghatta Road, 9th Block Jayanagar, Bangalore, Karnataka, India
Click here for correspondence address and
|Date of Submission||20-Feb-2022|
|Date of Acceptance||07-Apr-2022|
|Date of Web Publication||05-Jul-2022|
| Abstract|| |
Aim: To determine the factors associated with an inadequate response to adenosine infusion during cardiac stress magnetic resonance imaging (MRI).
Study Design: It is a retrospective cohort study.
Introduction: Stress cardiac MRI is a highly accurate and non-invasive method to diagnose coronary artery disease (CAD). Stress MRI is performed by inducing stress with adenosine infusion. There is an increase in systemic and myocardial blood flow (MBF) with vasodilator agents. Capillaries are maximally dilated in a diseased artery and cannot sustain increased myocardial oxygen demand. It results in delayed delivery of contrast, which leads to an area of perfusion defect in the myocardium. These perfusion defects can be accurately seen by cardiovascular magnetic resonance (CMR) and help in the prognosis of patients.
Methods: A retrospective study on patients subjected to cardiac stress MRI was conducted in a Tertiary Care Cardiac Center from January 2019 to January 2022. In total, 99 patients underwent adenosine stress perfusion cardiac MRI. All patients received an adenosine infusion of 140 mcg/kg/min for 2 min. Subsequently, the dosage was increased by 20 mcg/kg/min every 2 min to a maximum of 210 mcg/kg/min until an adequate stress response was achieved. Adequate stress was defined as two or more of the following criteria: 1) Increase in heart rate >/= 10 beats per minute. 2) Decrease in systolic blood pressure SBP by >/= 10 mm Hg Symptoms like chest discomfort, breathlessness, and headache. Patients who satisfied two or more of the above criteria were labeled as responders and the patients who did not satisfy the above criteria with the maximum dose of 210 mcg/kg/min of adenosine infusion were labeled as non-responders. Multivariable logistic regression analysis with forward and backward stepwise selection was used to identify predictors in non-responders. Basic demographic variables with P value </= 0.2 were examined for inclusion in the model. A P value </= 0.05 was considered significant.
Results: Nine patients (9.1%) showed inadequate stress response to adenosine infusion even with a maximum dose of 210 mcg/kg/min. Multivariate logistic regression analysis showed that left ventricular end-diastolic volume (LVEDV) was a predictor of inadequate response to adenosine infusion.
Conclusion: Inadequate stress response to adenosine occurred in 9.1% of subjects with an infusion of 140–210 ug/kg/min. LVEDV is an independent and strong predictor in non-responders.
Keywords: Adenosine, cardiac stress MRI, left ventricular end-diastolic volume
|How to cite this article:|
Gupta S, Simha PP, Singh NG, Nagaraja P S, Barthur A, Ganga K, Prabhakar V. Inadequate response to adenosine infusion during cardiac stress magnetic resonance imaging. Ann Card Anaesth 2022;25:330-4
|How to cite this URL:|
Gupta S, Simha PP, Singh NG, Nagaraja P S, Barthur A, Ganga K, Prabhakar V. Inadequate response to adenosine infusion during cardiac stress magnetic resonance imaging. Ann Card Anaesth [serial online] 2022 [cited 2023 Feb 3];25:330-4. Available from: https://www.annals.in/text.asp?2022/25/3/330/349929
| Introduction|| |
Ischemic heart disease remains one of the leading causes of death, accounting for over 9 million deaths per year worldwide.,
According to the American Heart Association, the annual incidence of new coronary events is approximately 720 000 cases per year, and the current prevalence of ischemic heart disease is approximately 18.2 million cases in the United States alone.
Invasive coronary angiography is considered the standard for detecting epicardial coronary artery stenosis, but it is expensive, carries some risk, and cannot assess the physiologic impact of stenosis.
Of the non-invasive imaging methods, stress perfusion imaging methods magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) have become the most widely used which help assess myocardial viability to varying degrees.
Indications of stress perfusion imaging include known or possible stable angina and assessing the physiologic significance of known coronary artery stenosis.,
Two sets of myocardial perfusion images of the heart are obtained during stress perfusion imaging: stress and rest. Stress images are obtained during the administration of a vasodilator medication (or at peak exercise stress), coordinated with an injection of contrast or radionuclide material.
Stress cardiac MRI is a highly accurate and non-invasive method to diagnose coronary artery disease (CAD). Stress MRI is performed by inducing stress with adenosine infusion. There is an increase in systemic and myocardial blood flow (MBF) with vasodilator agents. Capillaries are maximally dilated in a diseased artery and cannot sustain increased myocardial oxygen demand. It results in delayed delivery of contrast, which leads to an area of perfusion defect in the myocardium. These perfusion defects can be accurately seen by cardiovascular magnetic resonance (CMR) and help in the prognosis of patients.,,,,
Suboptimal physiological stress can be seen in patients who do not show adequate hemodynamic changes that is increased heart rate and decrease in blood pressure. Thus false-negative findings on stress CMR perfusion can be seen in patients with inadequate stress response, which further leads to suboptimal clinical management. AIM of the present study is to determine the factors associated with an inadequate response to adenosine infusion during cardiac stress MRI.
| Methods|| |
This was a retrospective analysis from January 2019 to January 2022. Patients undergoing adenosine stress perfusion CMR were included. The inclusion criteria were patients with known or suspected CAD. Exclusion criteria were patients with asthma, unstable angina, acute myocardial infarction within two weeks of the study, and second or third-degree atrioventricular block. A 12-lead electrocardiogram (MR Philips System Ingenia CX) was performed before the CMR scan. All patients were asked to abstain from caffeine for 24 h before the scan. Beta-blockers, calcium channel blockers, and any drug known to decrease heart rate were stopped 24 h before the CMR scan. (Ethical committe approval was obtained from Institutional Ethical Committe Board).
All patients received an adenosine infusion rate of 140 ug/kg/min for 2 min. Heart rate (HR), blood pressure (BP), and symptoms were determined after adenosine infusion. If there was an inadequate response for the next 2 min, the dosage was increased by 20 ug/kg/min after 2 min to a maximum of 210 mcg/kg/min until adequate stress response was achieved. Adequate stress was defined as two or more of the following criteria: An increase in HR >/= 10 bpm, a decrease in systolic blood pressure (SBP) by >/= 10 mm Hg, and symptoms like chest discomfort, breathlessness, and headache. Patients who satisfied two or more of the above criteria were labeled as responders and the patients who did not satisfy the above criteria with the maximum dose of 210 mcg/kg/min of adenosine infusion were labeled as non-responders.
Once the patient is labeled as a responder, the infusion is continued for the next 2 min and stress perfusion imaging with a gadolinium dose of 0.1 mmol/kg was performed during the last minute of the adenosine infusion. Rest perfusion imaging was then performed after an appropriate delay using an additional gadolinium dose of 0.1 mmol/kg. Cine white blood imaging including short axis and two, three, and four-chamber long-axis views were performed using a steady-state free precession (SSFP) sequence to evaluate cardiac morphology and function. Delayed enhanced imaging was performed using a phase-sensitive inversion recovery (PSIR) sequence. Images were post-processed on a computer workstation to assess cardiac anatomy and ventricular function.
Field strength - 1.5 T
Patient parameters of age, height, weight, body surface area (BSA), gender, diabetes mellitus (DM), hypertension (HTN), hypothyroid, smoker, left ventricle ejection fraction, left ventricular end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV), left ventricular end-diastolic diameter (LVEDD), left ventricular systolic volume index (LVSVI), left atrial (LA) diameter, regional wall motion abnormality (RWMA), atrial fibrillation, heart rate, SBP, diastolic blood pressure (DBP) were recorded during rest and stress.
Splenic switch off sign was negative for non-responders.
Continuous variables were expressed as mean ± standard deviation and were assessed by an independent student t-test. Categorical variables were expressed as count and percentage. A comparison of categorical variables between groups was performed with Pearson's Chi-square test. Multivariable logistic regression analysis was performed for variables with P value </= 0.2. Multivariable logistic regression analysis with forward and backward stepwise selection and 95% confidence intervals to identify potential predictors of inadequate response were used. A P value </= 0.05 was considered significant and two-tailed P values were used for all statistics.
| Results|| |
Data were collected from 99 consecutive subjects. Ninety of 99 patients (90.90%) were responders. Nine of 99 (9.1%) patients were non-responders.
Predictors of inadequate stress from adenosine infusion of 210 ug/kg/min (non-responders)
Demographic variables that showed a trend towards significance (p < 0.2) and which are potential predictors of inadequate stress included male gender, smoker, higher BSA, and height.
Non-responders had significantly higher LVESV, LVEDV, LVEDD, LVSVI, and low left ventricular ejection fraction (LVEF), increased left atrial diameter, presence of RWMA, lower SBP at rest as tabulated in [Table 1].
There was a significant increase in HR, SBP, DBP in responder group after adenosine infusion whereas in non responders there was no significant increase in SBP and DBP [Table 2].
By multivariable logistic regression analysis, the predictors of inadequate stress were found to be only LVEDV [Table 3].
|Table 3: Multivariate logistic regression model for predictors in non-responders|
Click here to view
| Discussion|| |
Adenosine is a powerful vasoactive substance. There occurs dilatation of coronary and peripheral arterial beds, increase in myocardial blood flow, and sympatho-excitation upon activation of cardiac A2A and A2B adenosine receptors. As a result, there occurs a mild decrease in blood pressure and baroreceptor-mediated reflex tachycardia., Most of the patients show signs of sufficient peripheral vasodilatory response after 2–3 min of adenosine infusion at the standard dose of 140 ug/kg/min. However, some patients show a reduced response to the standard dose according to prior studies.,,
In the present study, 9 of 99 patients (9.1%) were non-responders.
In a study conducted by Cheng et al., 56 of 150 patients (37%) did not show adequate stress response with an adenosine triphosphate (ATP) infusion rate of 140 mcg/kg/min. Karamitsos et al. demonstrated that 18% of patients did not achieve adequate hemodynamic stress under the standard dose of 140 ug/kg/min.
Since the dosage in the above studies was limited to 140 ug/kg/min, more patients were non-responders. The lower percentage of non-responders in the present study is due to an increased dosage of adenosine with a maximum of 210 mcg/kg/min.
In the present study, no significant decrease in systolic and diastolic blood pressure [Table 2] was seen in the non-responder group only. But there was a significant increase in heart rate in both groups. Seventeen percent of patients in the non-responder and 35% of patients in the responder group had a significant increase in heart rate.
In a study by Brown et al., it was shown that there is no significant relationship between a rise in HR at standard dose adenosine (140 mcg/kg/min) and an increase in stress MBF with high dose adenosine which indicates that in patients with low HR response at standard dose adenosine, a higher dose does not increase myocardial perfusion. Also, no significant difference in SBP change was seen between the group of patients or adenosine doses.
In a study by Karamitsos et al., 18% of patients had an inadequate peripheral hemodynamic response to the standard infusion dose of adenosine. Impairment of the baroreceptor reflex, resulting in decreased vascular reactivity in response to vasodilator stimuli is a possible cause of reduced heart rate response. Diabetic or elderly patients have attenuated reflex tachycardia in response to vasodilator-induced decreased blood pressure, possibly attributable to autonomic dysfunction.
In the present study, the majority of patients in the responder group had chest discomfort (n = 62) as compared to non-responders (p < 0.01).
Among the non-responder group, one patient had CAD by coronary angiogram. Other patients were diagnosed with dilated cardiomyopathy, left ventricular non-compaction, and amyloidosis who had increased LVEDV.
In the present study, many factors like higher LVEDV, LVESV, LVEDD, LA diameter, low EF <40%, smokers, male gender, higher BSA, and height were found to be significant for non-responders (p < 0.2). But only high LVEDV was found to be statistically significant (p < 0.05).
The mechanism of lower adenosine response is the downregulation of gene expression of both adenosine receptors and adenosine deaminase in impaired myocardium, together with a decrease in the activity of adenosine deaminase.,
In chronic heart failure patients, increased levels of cardiac adenosine have been measured and this higher endogenous level explains the requirement for higher exogenous doses to achieve vasodilatation required in stress testing.,
Karamitsos et al. found a LVEF of less than 57% was associated with an inadequate peripheral hemodynamic response which can be due to an already increased sympathetic nervous activity known to be present in heart failure. Patients with heart failure have high resting peripheral vasomotor tone, which makes them less responsive to the vasodilator effect of adenosine. Also high catecholamine levels and endogenous adenosine formation act as a negative feedback system in patients with heart failure.
Cheng et al. found that low body weight and male gender were independent predictors of an inadequate stress response.
In the present study, a splenic switch-off sign was performed in non-responders and was found to be negative. If the patient is labeled as a non-responder, he is reviewed after ten days post-optimization.
Limitation of the study was that it was single centre and retrospective in nature.
| Conclusion|| |
LVEDV is an independent predictor of inadequate response to adenosine infusion during cardiac stress MRI.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019;12:e005375. doi: 10.1161/CIRCOUTCOMES.118.005375.
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al
. Heart disease and stroke statistics: 2020 update—A report from the American Heart Association. Circulation 2020;141:e139–596.
Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol 2016;23:606–39. [Published correction appears in J Nucl Cardiol 2016;23:640–2.].
Patel AR, Bamberg F, Branch K, Carrascosa P, Chen M, Cury RC, et al
. Society of cardiovascular computed tomography expert consensus document on myocardial computed tomography perfusion imaging. J Cardiovasc Comput Tomogr 2020;14:87–100.
Kwong RY, Ge Y, Steel K, Bingham S, Abdullah S, Fujikura K, et al
. Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain. J Am Coll Cardiol 2019;74:1741-55.
Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: A systematic review and meta-analysis. J Am Coll Cardiol 2013;62:826-38.
Khoo JP, Grundy BJ, Steadman CD, Sonnex EP, Coulden RA, McCann GP. Stress cardiovascular MR in routine clinical practice: Referral patterns, accuracy, tolerance, safety and incidental findings. Br J Radiol 2012;85:e851-7.
Hamon M, Fau G, Nee G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010;12:29.
Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, et al
. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.
Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994;23:384-9.
Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res 1987;61:779-86.
Johnston DL, Hodge DO, Hopfenspirger MR, Gibbons RJ. Clinical determinants of hemodynamic and symptomatic responses in 2,000 patients during adenosine scintigraphy. Mayo Clin Proc 1998;73:314-20.
Abidov A, Hachamovitch R, Hayes SW, Ng CK, Cohen I, Friedman JD, et al
. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation 2003;107:2894-9.
Cheng AK, Li JY, Lam SH, Cheung SC. Factors determining inadequate stress response to adenosine triphosphate in perfusion cardiovascular magnetic resonance. Cardiovasc Imaging Asia 2018;2:194-201.
Karamitsos TD, Ntusi NA, Francis JM, Holloway CJ, Myerson SG, Neubauer S. Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:66.
Brown LAE, Saunderson CED, Das A, Craven T, Levelt E, Knott KD, et al
. A comparison of standard and high dose adenosine protocols in routine vasodilator stress cardiovascular magnetic resonance: Dosage affects hyperaemic myocardial blood flow in patients with severe left ventricular systolic impairement. J Cardiovasc Magn Reson 2021;23:37
Asakura M, Asanuma H, Kim J, Liao Y, Nakamaru K, Fujita M, et al
. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res 2007;30:781–7.
Headrick JP, Peart JN, Reichelt ME, Haseler LJ. Adenosine and its receptors in the heart: Regulation, retaliation and adaptation. Biochim Biophys Acta 2011;1808:1413–28.
Room 105 Doctor's Accommodation, Jayadeva Hospital Bangalore, Karnataka
Source of Support: None, Conflict of Interest: None
[Table 1], [Table 2], [Table 3]